Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Solu Therapeutics in the transaction.Solu Therapeutics announced the closing of an oversubscribed $31 million seed financing co-led by…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
